Stem Cell Kidney Transplant Clinical Trials

But research is underway to keep people from reaching that point.

Stem cell kidney transplant clinical trials.

Scientists are working on a promising approach to treat chronic kidney disease and kidney failure by harnessing the unique properties of human amniotic fluid derived stem cells the mixture of stem cells that can be obtained from the fluid surrounding a fetus within the innermost membrane that encloses the embryo of a mammal. The harvard stem cell institute is developing new therapies to repair kidney damage reducing the need for dialysis and transplantation. Stem cells scs currently considered as a promising tool for therapeutic application have aroused considerable interest and expectations. Hundreds of thousands will progress to end stage kidney disease requiring either dialysis or kidney transplant.

Our goal is to take a look at how we can repair the diabetic kidney in terms of delaying the rate of progression of kidney failure says latonya hickson m d. Diabetes is a corrosive illness. At present though there is no known cure for kidney failure. Diabetic kidney disease also known as diabetic nephropathy is the most common cause of chronic kidney disease and end stage kidney failure requiring dialysis or kidney transplantation.

For this study researchers found that amniotic fluid stem cells injected into a diseased kidney in a pre clinical model led to improvement of kidney function based on measured waste levels after. Adult stem cells basic research clinical trials discovery research kidney disease stem cell research anthony atala breast cancer cd133 cisplatin kidney dialysis kidney disease organ transplant prostate cancer rodney dangerfield stem cells translational medicine university of torino wake forest wake forest institute. The imbalance of blood sugar causes small changes in the body that slowly lead to blurry vision skin rashes and damaged nerves. The prevalence of kidney diseases is emerging as a public health problem.

This is being tested in a phase 3 clinical trial and it s hoped it will eliminate the need for immunosuppressive drugs in genetically matched kidney transplant patients. But that said stem cell kidney therapy is proving to be promising in early trials and may hold the answer for better treatment or even for a cure perhaps in the form of complete stem cell kidney regeneration in the future. To tackle this problem medeor is developing a stem cell based therapy called mdr 101.